Experimental PfSPZ malaria vaccine provides durable protection against multiple strains in NIH clinical trial
21/02/2017
Earlier research found the vaccine to be safe, well-tolerated and protective for more than a year
Earlier research found the vaccine to be safe, well-tolerated and protective for more than a year